HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J A Engelman Selected Research

J A Engelman Research Topics

Disease

5Neoplasms (Cancer)
11/2017 - 10/2000
2Lung Neoplasms (Lung Cancer)
11/2017 - 04/2010
2Colorectal Neoplasms (Colorectal Cancer)
11/2017 - 09/2010
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2013 - 12/2011
1Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy)
06/2001
1Cachexia
10/2000
1Insulin Resistance
10/2000
1Obesity
10/2000
1Bacterial Infections (Bacterial Infection)
10/2000
1Carcinogenesis
02/2000

Drug/Important Bio-Agent (IBA)

2Phosphotransferases (Kinase)IBA
04/2010 - 10/2000
1SAR405838IBA
11/2017
1N- (2,3- dihydroxypropyl)- 1- ((2- fluoro- 4- iodophenyl)amino)isonicotinamideIBA
11/2017
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2017
1Pemetrexed (MTA)FDA Link
01/2013
1CrizotinibIBA
01/2013
1Anaplastic Lymphoma KinaseIBA
01/2013
1AMP-Activated Protein KinasesIBA
09/2010
1dacomitinibIBA
04/2010
1Gefitinib (Iressa)FDA Link
04/2010
1ErbB Receptors (EGF Receptor)IBA
04/2010
1Tyrosine Kinase InhibitorsIBA
04/2010
1Erlotinib Hydrochloride (CP 358,774)FDA Link
04/2010
1Caveolin 3IBA
06/2001
1Serine (L-Serine)FDA Link
10/2000
1Insulin (Novolin)FDA Link
10/2000
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2000
1Tyrosine (L-Tyrosine)FDA Link
10/2000
1Insulin Receptor Substrate ProteinsIBA
10/2000
1Proteins (Proteins, Gene)FDA Link
02/2000

Therapy/Procedure

3Therapeutics
11/2017 - 04/2010
1Drug Therapy (Chemotherapy)
01/2013